Short answer
Amphastar Pharmaceuticals, Inc. (AMPH) filed an 8-K current report with the SEC on March 16, 2026 reporting Item 8.01 (Other Events). Board authorized $50M increase to existing share buyback program on March 12, 2026.
Amphastar Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Board authorized $50M increase to existing share buyback program on March 12, 2026
- Program runs indefinitely; primary purpose is offsetting dilution from equity compensation, not aggressive capital return
- Purchases via open market, Rule 10b5-1 plans, or private transactions: timing and volume at management's discretion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Amphastar Pharmaceuticals, Inc. 8-K filings
Get the next AMPH 8-K as it lands
Follow AMPH for push alerts, or ask the research agent what this filing means.